Copyright Reports & Markets. All rights reserved.

Global Fish-Oil Based Drugs Market Growth 2021-2026

Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Fish-Oil Based Drugs Consumption 2016-2026
    • 2.1.2 Fish-Oil Based Drugs Consumption CAGR by Region
  • 2.2 Fish-Oil Based Drugs Segment by Type
    • 2.2.1 Mackerel
    • 2.2.2 Tuna
    • 2.2.3 Herring
    • 2.2.4 Salmon
    • 2.2.5 Others
  • 2.3 Fish-Oil Based Drugs Sales by Type
    • 2.3.1 Global Fish-Oil Based Drugs Sales Market Share by Type (2016-2021)
    • 2.3.2 Global Fish-Oil Based Drugs Revenue and Market Share by Type (2016-2021)
    • 2.3.3 Global Fish-Oil Based Drugs Sale Price by Type (2016-2021)
  • 2.4 Fish-Oil Based Drugs Segment by Application
    • 2.4.1 Coronary Heart Disease (CHD)
    • 2.4.2 Rheumatoid Arthritis
    • 2.4.3 Stroke
    • 2.4.4 Raynaud's Syndrome
    • 2.4.5 Dysmenorrhea
    • 2.4.6 Other
  • 2.5 Fish-Oil Based Drugs Sales by Application
    • 2.5.1 Global Fish-Oil Based Drugs Sale Market Share by Application (2016-2021)
    • 2.5.2 Global Fish-Oil Based Drugs Revenue and Market Share by Application (2016-2021)
    • 2.5.3 Global Fish-Oil Based Drugs Sale Price by Application (2016-2021)

3 Global Fish-Oil Based Drugs by Company

  • 3.1 Global Fish-Oil Based Drugs Sales Market Share by Company
    • 3.1.1 Global Fish-Oil Based Drugs Sales by Company (2019-2021)
    • 3.1.2 Global Fish-Oil Based Drugs Sales Market Share by Company (2019-2021)
  • 3.2 Global Fish-Oil Based Drugs Revenue Market Share by Company
    • 3.2.1 Global Fish-Oil Based Drugs Revenue by Company (2019-2021)
    • 3.2.2 Global Fish-Oil Based Drugs Revenue Market Share by Company (2019-2021)
  • 3.3 Global Fish-Oil Based Drugs Sale Price by Company
  • 3.4 Global Manufacturers Fish-Oil Based Drugs Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers Fish-Oil Based Drugs Product Location Distribution
    • 3.4.2 Players Fish-Oil Based Drugs Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 Fish-Oil Based Drugs by Region

  • 4.1 Global Fish-Oil Based Drugs by Region
    • 4.1.1 Global Fish-Oil Based Drugs Sales by Region
    • 4.1.2 Global Fish-Oil Based Drugs Revenue by Region
  • 4.2 Americas Fish-Oil Based Drugs Sales Growth
  • 4.3 APAC Fish-Oil Based Drugs Sales Growth
  • 4.4 Europe Fish-Oil Based Drugs Sales Growth
  • 4.5 Middle East & Africa Fish-Oil Based Drugs Sales Growth

5 Americas

  • 5.1 Americas Fish-Oil Based Drugs Sales by Country
    • 5.1.1 Americas Fish-Oil Based Drugs Sales by Country (2016-2021)
    • 5.1.2 Americas Fish-Oil Based Drugs Revenue by Country (2016-2021)
  • 5.2 Americas Fish-Oil Based Drugs Sales by Type
  • 5.3 Americas Fish-Oil Based Drugs Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Fish-Oil Based Drugs Sales by Region
    • 6.1.1 APAC Fish-Oil Based Drugs Sales by Region (2016-2021)
    • 6.1.2 APAC Fish-Oil Based Drugs Revenue by Region (2016-2021)
  • 6.2 APAC Fish-Oil Based Drugs Sales by Type
  • 6.3 APAC Fish-Oil Based Drugs Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Fish-Oil Based Drugs by Country
    • 7.1.1 Europe Fish-Oil Based Drugs Sales by Country (2016-2021)
    • 7.1.2 Europe Fish-Oil Based Drugs Revenue by Country (2016-2021)
  • 7.2 Europe Fish-Oil Based Drugs Sales by Type
  • 7.3 Europe Fish-Oil Based Drugs Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Fish-Oil Based Drugs by Country
    • 8.1.1 Middle East & Africa Fish-Oil Based Drugs Sales by Country (2016-2021)
    • 8.1.2 Middle East & Africa Fish-Oil Based Drugs Revenue by Country (2016-2021)
  • 8.2 Middle East & Africa Fish-Oil Based Drugs Sales by Type
  • 8.3 Middle East & Africa Fish-Oil Based Drugs Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Country

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers and Impact
    • 9.1.1 Growing Demand from Key Regions
    • 9.1.2 Growing Demand from Key Applications and Potential Industries
  • 9.2 Market Challenges and Impact
  • 9.3 Market Trends

10 Marketing, Distributors and Customer

  • 10.1 Sales Channel
    • 10.1.1 Direct Channels
    • 10.1.2 Indirect Channels
  • 10.2 Fish-Oil Based Drugs Distributors
  • 10.3 Fish-Oil Based Drugs Customer

11 Global Fish-Oil Based Drugs Market Forecast

  • 11.1 Global Fish-Oil Based Drugs Forecast by Region
    • 11.1.1 Global Fish-Oil Based Drugs Forecast by Regions (2021-2026)
    • 11.2.2 Global Fish-Oil Based Drugs Revenue Forecast by Regions (2021-2026)
  • 11.2 Americas Forecast by Country
  • 11.3 APAC Forecast by Region
  • 11.4 Europe Forecast by Country
  • 11.5 Middle East & Africa Forecast by Country
  • 11.6 Global Fish-Oil Based Drugs Forecast by Type
  • 11.7 Global Fish-Oil Based Drugs Forecast by Application

12 Key Players Analysis

  • 12.1 Solutex GC
    • 12.1.1 Solutex GC Company Information
    • 12.1.2 Solutex GC Fish-Oil Based Drugs Product Offered
    • 12.1.3 Solutex GC Fish-Oil Based Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
    • 12.1.4 Solutex GC Main Business Overview
    • 12.1.5 Solutex GC Latest Developments
  • 12.2 Aker Biomarine
    • 12.2.1 Aker Biomarine Company Information
    • 12.2.2 Aker Biomarine Fish-Oil Based Drugs Product Offered
    • 12.2.3 Aker Biomarine Fish-Oil Based Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
    • 12.2.4 Aker Biomarine Main Business Overview
    • 12.2.5 Aker Biomarine Latest Developments
  • 12.3 Croda International PLC
    • 12.3.1 Croda International PLC Company Information
    • 12.3.2 Croda International PLC Fish-Oil Based Drugs Product Offered
    • 12.3.3 Croda International PLC Fish-Oil Based Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
    • 12.3.4 Croda International PLC Main Business Overview
    • 12.3.5 Croda International PLC Latest Developments
  • 12.4 Stepan Company
    • 12.4.1 Stepan Company Company Information
    • 12.4.2 Stepan Company Fish-Oil Based Drugs Product Offered
    • 12.4.3 Stepan Company Fish-Oil Based Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
    • 12.4.4 Stepan Company Main Business Overview
    • 12.4.5 Stepan Company Latest Developments
  • 12.5 Pharma Marine
    • 12.5.1 Pharma Marine Company Information
    • 12.5.2 Pharma Marine Fish-Oil Based Drugs Product Offered
    • 12.5.3 Pharma Marine Fish-Oil Based Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
    • 12.5.4 Pharma Marine Main Business Overview
    • 12.5.5 Pharma Marine Latest Developments
  • 12.6 GC Rieber Oil
    • 12.6.1 GC Rieber Oil Company Information
    • 12.6.2 GC Rieber Oil Fish-Oil Based Drugs Product Offered
    • 12.6.3 GC Rieber Oil Fish-Oil Based Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
    • 12.6.4 GC Rieber Oil Main Business Overview
    • 12.6.5 GC Rieber Oil Latest Developments
  • 12.7 Clover Corporation
    • 12.7.1 Clover Corporation Company Information
    • 12.7.2 Clover Corporation Fish-Oil Based Drugs Product Offered
    • 12.7.3 Clover Corporation Fish-Oil Based Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
    • 12.7.4 Clover Corporation Main Business Overview
    • 12.7.5 Clover Corporation Latest Developments
  • 12.8 BASF SE
    • 12.8.1 BASF SE Company Information
    • 12.8.2 BASF SE Fish-Oil Based Drugs Product Offered
    • 12.8.3 BASF SE Fish-Oil Based Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
    • 12.8.4 BASF SE Main Business Overview
    • 12.8.5 BASF SE Latest Developments
  • 12.9 Cellana
    • 12.9.1 Cellana Company Information
    • 12.9.2 Cellana Fish-Oil Based Drugs Product Offered
    • 12.9.3 Cellana Fish-Oil Based Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
    • 12.9.4 Cellana Main Business Overview
    • 12.9.5 Cellana Latest Developments
  • 12.10 Omega Protein Corporation
    • 12.10.1 Omega Protein Corporation Company Information
    • 12.10.2 Omega Protein Corporation Fish-Oil Based Drugs Product Offered
    • 12.10.3 Omega Protein Corporation Fish-Oil Based Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
    • 12.10.4 Omega Protein Corporation Main Business Overview
    • 12.10.5 Omega Protein Corporation Latest Developments
  • 12.11 United Laboratories
    • 12.11.1 United Laboratories Company Information
    • 12.11.2 United Laboratories Fish-Oil Based Drugs Product Offered
    • 12.11.3 United Laboratories Fish-Oil Based Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
    • 12.11.4 United Laboratories Main Business Overview
    • 12.11.5 United Laboratories Latest Developments

13 Research Findings and Conclusion

According to this latest study, the 2021 growth of Fish-Oil Based Drugs will have significant change from previous year. By the most conservative estimates of global Fish-Oil Based Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Fish-Oil Based Drugs market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Fish-Oil Based Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Mackerel
Tuna
Herring
Salmon
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Coronary Heart Disease (CHD)
Rheumatoid Arthritis
Stroke
Raynaud's Syndrome
Dysmenorrhea
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Solutex GC
Aker Biomarine
Croda International PLC
Stepan Company
Pharma Marine
GC Rieber Oil
Clover Corporation
BASF SE
Cellana
Omega Protein Corporation
United Laboratories

Buy now